Evidence map›Paper›PMID 33320881›Full record

ArticlePloS one2020

Assessment of the impact of inpatient infectious events in pediatric patients with newly diagnosed acute leukemia at Dr. Robert Reid Cabral Children's Hospital, Dominican Republic.

Julianne E Burns, Dominga Reyes Pérez, Yimei Li, Wendy Gómez García, F Jay Garcia, Johanna Penélope Gil Jiménez, Jacqueline Sánchez, María Castillo Bueno, Stephen P Hunger, Lisa Reaves and 5 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 45% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 4 institutions in 2 countries.

Julianne E BurnsDivision of Infectious Diseases, Department of Pediatrics, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States of America.ORCID 0000-0003-4154-2802
Dominga Reyes PérezDepartment of Oncology, Hospital Infantil Dr. Robert Reid Cabral, Santo Domingo, National District, Dominican Republic.
Yimei LiDepartment of Biostatistics, Epidemiology, and Informatics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, United States of America.
Wendy Gómez GarcíaDepartment of Oncology, Hospital Infantil Dr. Robert Reid Cabral, Santo Domingo, National District, Dominican Republic.ORCID 0000-0002-6457-3559
F Jay GarciaDepartment of Pediatrics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, United States of America.ORCID 0000-0001-7495-143X
Johanna Penélope Gil JiménezDepartment of Oncology, Hospital Infantil Dr. Robert Reid Cabral, Santo Domingo, National District, Dominican Republic.
Jacqueline SánchezMicrobiology Laboratory, Department of Infectious Diseases, Hospital Infantil Dr. Robert Reid Cabral, Santo Domingo, National District, Dominican Republic.
María Castillo BuenoDepartment of Oncology, Hospital Infantil Dr. Robert Reid Cabral, Santo Domingo, National District, Dominican Republic.
Stephen P HungerDepartment of Pediatrics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, United States of America.
Lisa ReavesCenter for Cancer and Blood Disorders, Children's Hospital Colorado, Colorado Springs, Colorado, United States of America.
Johanny Contreras GonzálezDepartment of Oncology, Hospital Infantil Dr. Robert Reid Cabral, Santo Domingo, National District, Dominican Republic.
Susan E CoffinDivision of Infectious Diseases, Department of Pediatrics, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States of America.
Adriana DeverlisGlobal Health Center, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States of America.
Andrew P SteenhoffDivision of Infectious Diseases, Department of Pediatrics, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States of America.
Brian T FisherDivision of Infectious Diseases, Department of Pediatrics, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States of America.
Children's Hospital of Philadelphia · USHospital Infantil Dr. Robert Reid Cabral · DOChildren's Hospital Colorado · USUniversity of Pennsylvania · US

Funding

UNIVERSITY OF PENNSYLVANIA CAN CTR SUPPORT GRANTP30CA016520 · NCI · UNIVERSITY OF PENNSYLVANIA · PI SHELLEY L BERGER · 1985 to 2026
$222.3M
Infectious Diseases Epidemiology Training GrantT32AI055435 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI LAUTENBACH, EBBING · 2003 to 2023
$6.9M
NCI NIH HHS P30 CA016520NIAID NIH HHS T32 AI055435
6 · The paper itself

Abstract

Survival rates for pediatric acute leukemia vary dramatically worldwide. Infections are a leading cause of morbidity and mortality, and the impact is amplified in low and middle-income countries. Defining the epidemiology of infection in a specific health care setting is paramount to developing effective interventions. This study aimed to define the epidemiology of and outcomes from infection in children with acute leukemia treated in a large public pediatric hospital in the Dominican Republic. A retrospective cohort was assembled of children newly diagnosed with acute leukemia between July 1, 2015 to June 30, 2017 at Hospital Infantil Dr. Robert Reid Cabral in Santo Domingo. Patients were identified from the Pediatric Oncology Network Database (PONDTM) and hospital admissions from the Oncology admissions logbook. Medical records and microbiology results were reviewed to identify all inpatient invasive infections. Distance from a child's home to the hospital was determined using ArcGIS by Esri. Infection rates were described in discrete time periods after diagnosis and risk factors for invasive infection were explored using negative binomial regression. Overall, invasive infections were common and a prominent source of death in this cohort. Rates were highest in the first 60 days after diagnosis. Gastroenteritis/colitis, cellulitis, and pneumonia were most frequent, with bacteremia common early on. Multidrug resistant bacteria were prevalent among a small number of positive cultures. In a multivariate negative binomial regression model, age ≥ 10 years and distance from the hospital > 100 km were each protective against invasive infection in the first 180 days after diagnosis, findings that were unexpected and warrant further investigation. Over one-third of patient deaths were related to infection. Interventions aimed at reducing infection should target the first 60 days after diagnosis, improved supportive care inside and outside the hospital, and increased antimicrobial stewardship and infection prevention and control measures.

Indexed as

AdolescentChildChild, PreschoolDominican RepublicFemaleHospitalsHospitals, PediatricHumansInfantInfectionsInpatientsLeukemia, Myeloid, AcuteMalePrognosisRetrospective Studies

Identifiers

PMID33320881
PMCPMC7737966
OpenAlexW3111655605

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.